FR2873294B1 - Association de medicaments - Google Patents
Association de medicamentsInfo
- Publication number
- FR2873294B1 FR2873294B1 FR0408257A FR0408257A FR2873294B1 FR 2873294 B1 FR2873294 B1 FR 2873294B1 FR 0408257 A FR0408257 A FR 0408257A FR 0408257 A FR0408257 A FR 0408257A FR 2873294 B1 FR2873294 B1 FR 2873294B1
- Authority
- FR
- France
- Prior art keywords
- drugs
- association
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408257A FR2873294B1 (fr) | 2004-07-26 | 2004-07-26 | Association de medicaments |
CA002575848A CA2575848A1 (fr) | 2004-07-26 | 2005-07-26 | Medicament destine au traitement des desordres du systeme nerveux central |
JP2007523117A JP2008507577A (ja) | 2004-07-26 | 2005-07-26 | 中枢神経系の障害を治療するための医薬 |
PCT/FR2005/001942 WO2006018538A1 (fr) | 2004-07-26 | 2005-07-26 | Medicament destine au traitement des desordres du systeme nerveux central |
US11/658,643 US20080194631A1 (en) | 2004-07-26 | 2005-07-26 | Medicament For the Treatment of Central Nervous System Disorders |
EP05793762A EP1773306A1 (fr) | 2004-07-26 | 2005-07-26 | Medicament destine au traitement des desordres du systeme nerveux central |
CNA2005800293340A CN101014325A (zh) | 2004-07-26 | 2005-07-26 | 治疗中枢神经系统病症的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408257A FR2873294B1 (fr) | 2004-07-26 | 2004-07-26 | Association de medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2873294A1 FR2873294A1 (fr) | 2006-01-27 |
FR2873294B1 true FR2873294B1 (fr) | 2008-05-09 |
Family
ID=34950699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0408257A Expired - Lifetime FR2873294B1 (fr) | 2004-07-26 | 2004-07-26 | Association de medicaments |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080194631A1 (fr) |
EP (1) | EP1773306A1 (fr) |
JP (1) | JP2008507577A (fr) |
CN (1) | CN101014325A (fr) |
CA (1) | CA2575848A1 (fr) |
FR (1) | FR2873294B1 (fr) |
WO (1) | WO2006018538A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2206781B1 (fr) | 2004-06-28 | 2015-12-02 | The University Of Western Australia | Oligonucléotides antisens permettant d'induire un saut d'exon et leurs procédés d'utilisation |
WO2009058261A1 (fr) * | 2007-10-31 | 2009-05-07 | Merck & Co., Inc. | Modulation du sommeil avec des antagonistes du récepteur nr2b |
DK3106166T3 (da) | 2008-02-29 | 2021-01-11 | Vm Therapeutics Llc | Forbindelser til behandling af smertesyndrom og andre lidelser |
ES2693459T3 (es) | 2009-11-12 | 2018-12-11 | The University Of Western Australia | Moléculas antisentido y métodos para el tratamiento de patologías |
FR2954699B1 (fr) * | 2009-12-30 | 2012-01-20 | Greenpharma Sas | Composition pharmaceutique pour le traitement de la dependance a l'alcool |
US9737531B2 (en) * | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
FR2976807B1 (fr) | 2011-06-24 | 2013-07-05 | Greenpharma Sas | Composition pharmaceutique pour le traitement de la dependance chez l'etre humain |
EP3633035A1 (fr) | 2013-03-14 | 2020-04-08 | Sarepta Therapeutics, Inc. | Compositions de saut d'exons pour le traitement de la dystrophie musculaire |
KR101858055B1 (ko) * | 2015-08-04 | 2018-05-15 | 아스테라스 세이야쿠 가부시키가이샤 | 탐스로신을 유효성분으로 포함하는 인지기능 개선용 조성물 |
US11103499B2 (en) * | 2016-08-26 | 2021-08-31 | EXCIVA (UG) (haftungsbeschränkt) | Compositions and methods thereof |
KR20200046525A (ko) * | 2018-10-24 | 2020-05-07 | 건국대학교 글로컬산학협력단 | 피렌페론 화합물을 유효성분으로 포함하는 취약 x 증후군 및 관련 발달 장애치료용 조성물 |
CN115844898A (zh) * | 2022-12-02 | 2023-03-28 | 浙江工业大学 | 布那唑嗪在制备预防或治疗酒精使用障碍的药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87710A (en) * | 1987-09-18 | 1992-06-21 | Ciba Geigy Ag | Covered floating retard form for controlled release in gastric juice |
CN1210726A (zh) * | 1997-09-08 | 1999-03-17 | 郑万伦 | 一种快速脱毒的戒毒药品 |
EP1430890A4 (fr) * | 2001-09-26 | 2007-01-17 | Mitsubishi Pharma Corp | Inhibiteurs de thrombus/thrombogenese |
-
2004
- 2004-07-26 FR FR0408257A patent/FR2873294B1/fr not_active Expired - Lifetime
-
2005
- 2005-07-26 EP EP05793762A patent/EP1773306A1/fr not_active Withdrawn
- 2005-07-26 CA CA002575848A patent/CA2575848A1/fr not_active Abandoned
- 2005-07-26 WO PCT/FR2005/001942 patent/WO2006018538A1/fr active Application Filing
- 2005-07-26 US US11/658,643 patent/US20080194631A1/en not_active Abandoned
- 2005-07-26 JP JP2007523117A patent/JP2008507577A/ja active Pending
- 2005-07-26 CN CNA2005800293340A patent/CN101014325A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101014325A (zh) | 2007-08-08 |
JP2008507577A (ja) | 2008-03-13 |
WO2006018538A1 (fr) | 2006-02-23 |
FR2873294A1 (fr) | 2006-01-27 |
US20080194631A1 (en) | 2008-08-14 |
EP1773306A1 (fr) | 2007-04-18 |
CA2575848A1 (fr) | 2006-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2867064B1 (fr) | Doseur de medicaments | |
DE602005026188D1 (de) | Medikamentenspender | |
CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
PT1957073E (pt) | Medicamento | |
DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
MA28489B1 (fr) | Preparations pharmaceutiques | |
BRPI0511900A (pt) | composições farmacêuticas | |
DK2399580T3 (da) | Farmaceutiske doseringsformer | |
DK1757293T3 (da) | Bh4-responsiv hyperphenylalaninæmi-medikamenter | |
FR2873294B1 (fr) | Association de medicaments | |
DE602005017643D1 (de) | Medikamentenverdunster | |
ITMI20041447A1 (it) | Composizione farmaceutica comprendente gabapentina | |
NO20034952D0 (no) | Farmasöytiske forbindelser | |
ITMI20040943A1 (it) | Composizione farmaceutica cicatrizzante | |
ITRM20030053A1 (it) | Associazione di farmaci antidiabetici. | |
DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
SE0400990D0 (sv) | Läkemedel | |
FI20040558A0 (fi) | Farmaseuttinen valmiste | |
UA10054S (uk) | Упаковка фармацевтичного засобу | |
UA10038S (uk) | Упаковка фармацевтичного засобу | |
UA10535S (uk) | Упаковка фармацевтичного засобу | |
UA10843S (uk) | Упаковка фармацевтичного засобу | |
UA10842S (uk) | Піктограма фармацевтичного засобу | |
UA10644S (uk) | Піктограма фармацевтичного засобу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |
|
PLFP | Fee payment |
Year of fee payment: 20 |